In order to reduce the price of antibody drugs, which are ever soaring, high efficiency and low manufacturing process costs are required.
- Technology to create diversity in a uniform cell pool and develop cells with several outstanding characteristics
- Technology to screen for cells with desired characteristics from various cell pools
- Technology to establish immortalized cell lines from primary tissue culture
- Technology to develop test methods to comply with regulations for drug application
- Through collaboration or consigned development with domestic and international pharmaceutical companies, we continue to produce new cell lines.
- As a member of Manufacturing Technology Association of Biologics (MAB, AMED project), we are in charge of constructing the cell bank.
Manufacturing Technology Association of Biologics (AMED)